Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

<p>Abstract</p> <p>Background</p> <p>The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and we compared the risk str...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Christodoulou Christos, Skolarikos Andreas, Xanthakis Ioannis, Stravodimos Kostas, Anastasiou Ioannis, Kontovinis Loukas, Andreadis Charalambos, Papazisis Kostas, Timotheadou Eleni, Malettou Lia, Lainakis George, Lampaki Sofia, Karadimou Alexandra, Bamias Aristotelis, Syrigos Kostas, Papandreou Christos, Razi Evangelia, Dafni Urania, Fountzilas George, Dimopoulos Meletios A
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2010-02-01
סדרה:	BMC Cancer
גישה מקוונת:	http://www.biomedcentral.com/1471-2407/10/45
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!